Skip to main content
. 2018 Jul 15;29(14):1682–1692. doi: 10.1091/mbc.E18-02-0141

Table 2:

The siRNAs used in this study.

Company siRNA Sequence
Dharmacon OnTARGETplus LATS1-1 GGUGAAGUCUGUCUAGCAA
LATS1-2 UAGCAUGGAUUUCAGUAAU
LATS1-3 GGUAGUUCGUCUAUAUUAU
LATS1-4 GAAUGGUACUGGACAAACU
LATS2-1 GCACGCAUUUUACGAAUUC
LATS2-2 ACACUCACCUCGCCCAAUA
LATS2-3 AAUCAGAUAUUCCUUGUUG
LATS2-4 GAAGUGAACCGGCAAAUGC
TP53-1 GAAAUUUGCGUGUGGAGUA
TP53-2 GUGCAGCUGUGGGUUGAUU
TP53-3 GCAGUCAGAUCCUAGCGUC
TP53-4 GGAGAAUAUUUCACCCUUC
SPINT2-1 GAAGACCACUCCAGCGAUA
SPINT2-2 GCAAUAACUUCAUCUAUGG
SPINT2-3 CCUGCCAGCUGUUUGUGUA
SPINT2-4 CAGCAGGAAUGCAGCGGAU
Ambion Silencer Select NF2 (s224112) AGAUGGAGUUCAAUUGCGATT